scholarly journals Future and potential spending on health 2015–40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries

The Lancet ◽  
2017 ◽  
Vol 389 (10083) ◽  
pp. 2005-2030 ◽  
Author(s):  
Joseph L Dieleman ◽  
Madeline Campbell ◽  
Abigail Chapin ◽  
Erika Eldrenkamp ◽  
Victoria Y Fan ◽  
...  
2021 ◽  
Vol 6 (4) ◽  
pp. e004858
Author(s):  
Modhurima Moitra ◽  
Ian Cogswell ◽  
Emilie Maddison ◽  
Kyle Simpson ◽  
Hayley Stutzman ◽  
...  

IntroductionIn 2017, development assistance for health (DAH) comprised 5.3% of total health spending in low-income countries. Despite the key role DAH plays in global health-spending, little is known about the characteristics of assistance that may be associated with committed assistance that is actually disbursed. In this analysis, we examine associations between these characteristics and disbursement of committed assistance.MethodsWe extracted data from the Creditor Reporting System of the Organization for Economic Co-operation and Development, Institute for Health Metrics and Evaluation, and the WHO National Health Accounts database. Factors examined were off-budget assistance, administrative assistance, publicly sourced assistance and assistance to health systems strengthening. Recipient-country characteristics examined were perceived level of corruption, civil fragility and gross domestic product per capita (GDPpc). We used linear regression methods for panel of data to assess the proportion of committed aid that was disbursed for a given country-year, for each data source.ResultsFactors that were associated with a higher disbursement rates include off-budget aid (p<0.001), lower administrative expenses (p<0.01), lower perceived corruption in recipient country (p<0.001), lower fragility in recipient country (p<0.05) and higher GDPpc (p<0.05).ConclusionSubstantial gaps remain between commitments and disbursements. Characteristics of assistance (administrative, publicly sourced) and indicators of government transparency and fragility are also important drivers associated with disbursement of DAH. There remains a continued need for better aid flow reporting standards and clarity around aid types for better measurement of DAH.


Author(s):  
Bryan N Patenaude

Abstract This paper utilizes causal time-series and panel techniques to examine the relationship between development assistance for health (DAH) and domestic health spending, both public and private, in 134 countries between 2000 and 2015. Data on 237 656 donor transactions from the Institute for Health Metrics and Evaluation’s DAH and Health Expenditure datasets are merged with economic, demographic and health data from the World Bank Databank and World Health Organization’s Global Health Observatory. Arellano–Bond system GMM estimation is used to assess the effect of changes in DAH on domestic health spending and health outcomes. Analyses are conducted for the entire health sector and separately for HIV, TB and malaria financing. Results show that DAH had no significant impact on overall domestic public health investment. For HIV-specific investments, a $1 increase in on-budget DAH was associated with a $0.12 increase in government spending for HIV. For the private sector, $1 in DAH is associated with a $0.60 and $0.03 increase in prepaid private spending overall and for malaria, with no significant impact on HIV spending. Results demonstrate that a 1% increase in public financing reduced under-5 mortality by 0.025%, while a 1% increase in DAH had no significant effect on reducing under-5 mortality. The relationships between DAH and public health financing suggest that malaria and HIV-specific crowding-in effects are offset by crowding-out effects in other unobserved health sectors. The results also suggest policies that crowd-in public financing will likely have larger impacts on health outcomes than DAH investments that do not crowd-in public spending.


JAMA ◽  
2019 ◽  
Vol 321 (21) ◽  
pp. 2073 ◽  
Author(s):  
Joseph L. Dieleman ◽  
Angela E. Micah ◽  
Christopher J. L. Murray

The Lancet ◽  
2017 ◽  
Vol 389 (10083) ◽  
pp. 1981-2004 ◽  
Author(s):  
Joseph Dieleman ◽  
Madeline Campbell ◽  
Abigail Chapin ◽  
Erika Eldrenkamp ◽  
Victoria Y Fan ◽  
...  

2017 ◽  
Vol 36 (12) ◽  
pp. 2133-2141 ◽  
Author(s):  
Angela E. Micah ◽  
Bianca Zlavog ◽  
Sara Friedman ◽  
Alex Reynolds ◽  
Abigail L. Chapin ◽  
...  

2017 ◽  
Vol 12 (2) ◽  
pp. 207-221 ◽  
Author(s):  
Suerie Moon ◽  
Oluwatosin Omole

AbstractAfter a ‘golden age’ of extraordinary growth in the level of development assistance for health (DAH) since 1990, funding seems to have reached a plateau. With the launch of the Sustainable Development Goals, debate has intensified regarding what international financing for health should look like in the post-2015 era. In this review paper, we offer a systematic overview of problems and proposals for change. Major critiques of the current DAH system include: that the total volume of financing is inadequate; financial flows are volatile and uncertain; DAH may not result in additional resources for health; too small a proportion of DAH is transferred to recipient countries; inappropriate priority setting; inadequate coordination; weak mechanisms for accountability; and disagreement on the rationale for DAH. Proposals to address these critiques include: financing-oriented proposals to address insufficient levels and high volatility of DAH; governance-oriented proposals to address concerns regarding additionality, proportions reaching countries, priority setting, coordination and accountability; and proposals that reach beyond the existing DAH system. We conclude with a discussion of prospects for change.


The Lancet ◽  
2018 ◽  
Vol 391 (10132) ◽  
pp. 1799-1829 ◽  
Author(s):  
Joseph L Dieleman ◽  
Annie Haakenstad ◽  
Angela Micah ◽  
Mark Moses ◽  
Cristiana Abbafati ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document